|Podcasts|December 9, 2021
Episode 97: Diving Into Our 2022 Pipeline Report
Author(s)Elaine Quilici, Miranda Schmalfuhs
Mike Ward, Global Head of Thought Leadership in the Decision Resources Group at Clarivate, goes behind the numbers of our 2022 pipeline report and provides some interesting insights from the report provided by his company.
Advertisement
Mike Ward, Global Head of Thought Leadership in the Decision Resources Group at Clarivate, discusses our 2022 pipeline report, appearing in our December issue. Mike goes behind the numbers and provides some interesting insights from the report provided by Clarivate.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5